nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2C8—Omeprazole—Barrett's esophagus	0.14	0.238	CbGbCtD
Irbesartan—CYP1A2—Omeprazole—Barrett's esophagus	0.108	0.184	CbGbCtD
Irbesartan—CYP2C9—Omeprazole—Barrett's esophagus	0.0974	0.166	CbGbCtD
Irbesartan—CYP3A4—Esomeprazole—Barrett's esophagus	0.0961	0.164	CbGbCtD
Irbesartan—CYP2D6—Omeprazole—Barrett's esophagus	0.0891	0.152	CbGbCtD
Irbesartan—CYP3A4—Omeprazole—Barrett's esophagus	0.0566	0.0965	CbGbCtD
Irbesartan—JUN—exocrine gland—Barrett's esophagus	0.00839	0.236	CbGeAlD
Irbesartan—UGT1A3—digestive system—Barrett's esophagus	0.00491	0.138	CbGeAlD
Irbesartan—JUN—epithelium—Barrett's esophagus	0.00365	0.103	CbGeAlD
Irbesartan—JUN—smooth muscle tissue—Barrett's esophagus	0.00352	0.099	CbGeAlD
Irbesartan—Anorectal disorder—Omeprazole—Barrett's esophagus	0.00329	0.0123	CcSEcCtD
Irbesartan—Anorectal disorder—Esomeprazole—Barrett's esophagus	0.00329	0.0123	CcSEcCtD
Irbesartan—Sleep disturbance—Esomeprazole—Barrett's esophagus	0.00309	0.0115	CcSEcCtD
Irbesartan—Sleep disturbance—Omeprazole—Barrett's esophagus	0.00309	0.0115	CcSEcCtD
Irbesartan—JUN—digestive system—Barrett's esophagus	0.00278	0.0782	CbGeAlD
Irbesartan—AGTR1—epithelium—Barrett's esophagus	0.00275	0.0774	CbGeAlD
Irbesartan—AGTR1—smooth muscle tissue—Barrett's esophagus	0.00265	0.0746	CbGeAlD
Irbesartan—Nephritis interstitial—Omeprazole—Barrett's esophagus	0.00256	0.00959	CcSEcCtD
Irbesartan—Nephritis interstitial—Esomeprazole—Barrett's esophagus	0.00256	0.00959	CcSEcCtD
Irbesartan—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00226	0.00845	CcSEcCtD
Irbesartan—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00226	0.00845	CcSEcCtD
Irbesartan—Glycosuria—Omeprazole—Barrett's esophagus	0.00214	0.00799	CcSEcCtD
Irbesartan—Glycosuria—Esomeprazole—Barrett's esophagus	0.00214	0.00799	CcSEcCtD
Irbesartan—Proteinuria—Omeprazole—Barrett's esophagus	0.00197	0.00736	CcSEcCtD
Irbesartan—Proteinuria—Esomeprazole—Barrett's esophagus	0.00197	0.00736	CcSEcCtD
Irbesartan—Protein urine present—Esomeprazole—Barrett's esophagus	0.00194	0.00726	CcSEcCtD
Irbesartan—Protein urine present—Omeprazole—Barrett's esophagus	0.00194	0.00726	CcSEcCtD
Irbesartan—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00192	0.00716	CcSEcCtD
Irbesartan—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00192	0.00716	CcSEcCtD
Irbesartan—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00187	0.00698	CcSEcCtD
Irbesartan—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00187	0.00698	CcSEcCtD
Irbesartan—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00176	0.00659	CcSEcCtD
Irbesartan—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00176	0.00659	CcSEcCtD
Irbesartan—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00173	0.00647	CcSEcCtD
Irbesartan—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00173	0.00647	CcSEcCtD
Irbesartan—Oesophagitis—Omeprazole—Barrett's esophagus	0.00158	0.00591	CcSEcCtD
Irbesartan—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00158	0.00591	CcSEcCtD
Irbesartan—Lightheadedness—Omeprazole—Barrett's esophagus	0.00155	0.00579	CcSEcCtD
Irbesartan—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00155	0.00579	CcSEcCtD
Irbesartan—Ear pain—Omeprazole—Barrett's esophagus	0.00147	0.00551	CcSEcCtD
Irbesartan—Ear pain—Esomeprazole—Barrett's esophagus	0.00147	0.00551	CcSEcCtD
Irbesartan—Sleep disorder—Omeprazole—Barrett's esophagus	0.00145	0.00543	CcSEcCtD
Irbesartan—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00145	0.00543	CcSEcCtD
Irbesartan—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00144	0.00537	CcSEcCtD
Irbesartan—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00144	0.00537	CcSEcCtD
Irbesartan—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00143	0.00535	CcSEcCtD
Irbesartan—Photosensitivity—Omeprazole—Barrett's esophagus	0.00143	0.00535	CcSEcCtD
Irbesartan—Swelling—Omeprazole—Barrett's esophagus	0.00142	0.00532	CcSEcCtD
Irbesartan—Swelling—Esomeprazole—Barrett's esophagus	0.00142	0.00532	CcSEcCtD
Irbesartan—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00142	0.0053	CcSEcCtD
Irbesartan—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00142	0.0053	CcSEcCtD
Irbesartan—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00139	0.0052	CcSEcCtD
Irbesartan—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00139	0.0052	CcSEcCtD
Irbesartan—Injury—Esomeprazole—Barrett's esophagus	0.00137	0.00511	CcSEcCtD
Irbesartan—Injury—Omeprazole—Barrett's esophagus	0.00137	0.00511	CcSEcCtD
Irbesartan—Hot flush—Omeprazole—Barrett's esophagus	0.00134	0.00502	CcSEcCtD
Irbesartan—Hot flush—Esomeprazole—Barrett's esophagus	0.00134	0.00502	CcSEcCtD
Irbesartan—Increased appetite—Esomeprazole—Barrett's esophagus	0.00134	0.005	CcSEcCtD
Irbesartan—Increased appetite—Omeprazole—Barrett's esophagus	0.00134	0.005	CcSEcCtD
Irbesartan—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00133	0.00498	CcSEcCtD
Irbesartan—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00133	0.00498	CcSEcCtD
Irbesartan—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00133	0.00496	CcSEcCtD
Irbesartan—Visual disturbance—Omeprazole—Barrett's esophagus	0.00133	0.00496	CcSEcCtD
Irbesartan—Renal impairment—Omeprazole—Barrett's esophagus	0.00132	0.00494	CcSEcCtD
Irbesartan—Renal impairment—Esomeprazole—Barrett's esophagus	0.00132	0.00494	CcSEcCtD
Irbesartan—Arthritis—Omeprazole—Barrett's esophagus	0.00129	0.00483	CcSEcCtD
Irbesartan—Arthritis—Esomeprazole—Barrett's esophagus	0.00129	0.00483	CcSEcCtD
Irbesartan—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00126	0.00472	CcSEcCtD
Irbesartan—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00126	0.00472	CcSEcCtD
Irbesartan—Face oedema—Omeprazole—Barrett's esophagus	0.00121	0.00453	CcSEcCtD
Irbesartan—Face oedema—Esomeprazole—Barrett's esophagus	0.00121	0.00453	CcSEcCtD
Irbesartan—PTGS1—epithelium—Barrett's esophagus	0.00121	0.034	CbGeAlD
Irbesartan—PTGS1—smooth muscle tissue—Barrett's esophagus	0.00116	0.0328	CbGeAlD
Irbesartan—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00115	0.00429	CcSEcCtD
Irbesartan—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00115	0.00429	CcSEcCtD
Irbesartan—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00114	0.00427	CcSEcCtD
Irbesartan—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00114	0.00427	CcSEcCtD
Irbesartan—Breast disorder—Omeprazole—Barrett's esophagus	0.00114	0.00424	CcSEcCtD
Irbesartan—Breast disorder—Esomeprazole—Barrett's esophagus	0.00114	0.00424	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00113	0.00423	CcSEcCtD
Irbesartan—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00113	0.00423	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00113	0.00423	CcSEcCtD
Irbesartan—Cramp muscle—Omeprazole—Barrett's esophagus	0.00113	0.00423	CcSEcCtD
Irbesartan—Muscular weakness—Omeprazole—Barrett's esophagus	0.00111	0.00414	CcSEcCtD
Irbesartan—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00111	0.00414	CcSEcCtD
Irbesartan—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00109	0.00409	CcSEcCtD
Irbesartan—Abdominal distension—Omeprazole—Barrett's esophagus	0.00109	0.00409	CcSEcCtD
Irbesartan—Dysphagia—Esomeprazole—Barrett's esophagus	0.00109	0.00406	CcSEcCtD
Irbesartan—Asthma—Esomeprazole—Barrett's esophagus	0.00109	0.00406	CcSEcCtD
Irbesartan—Influenza—Esomeprazole—Barrett's esophagus	0.00109	0.00406	CcSEcCtD
Irbesartan—Influenza—Omeprazole—Barrett's esophagus	0.00109	0.00406	CcSEcCtD
Irbesartan—Asthma—Omeprazole—Barrett's esophagus	0.00109	0.00406	CcSEcCtD
Irbesartan—Dysphagia—Omeprazole—Barrett's esophagus	0.00109	0.00406	CcSEcCtD
Irbesartan—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00106	0.00398	CcSEcCtD
Irbesartan—Pancreatitis—Omeprazole—Barrett's esophagus	0.00106	0.00398	CcSEcCtD
Irbesartan—CYP1A2—digestive system—Barrett's esophagus	0.00106	0.0299	CbGeAlD
Irbesartan—Angina pectoris—Omeprazole—Barrett's esophagus	0.00106	0.00395	CcSEcCtD
Irbesartan—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00106	0.00395	CcSEcCtD
Irbesartan—Neutropenia—Esomeprazole—Barrett's esophagus	0.00102	0.0038	CcSEcCtD
Irbesartan—Neutropenia—Omeprazole—Barrett's esophagus	0.00102	0.0038	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00101	0.00377	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00101	0.00377	CcSEcCtD
Irbesartan—CYP2C9—digestive system—Barrett's esophagus	0.00101	0.0284	CbGeAlD
Irbesartan—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000991	0.00371	CcSEcCtD
Irbesartan—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000991	0.00371	CcSEcCtD
Irbesartan—Weight increased—Esomeprazole—Barrett's esophagus	0.000988	0.00369	CcSEcCtD
Irbesartan—Weight increased—Omeprazole—Barrett's esophagus	0.000988	0.00369	CcSEcCtD
Irbesartan—Renal failure—Omeprazole—Barrett's esophagus	0.000952	0.00356	CcSEcCtD
Irbesartan—Renal failure—Esomeprazole—Barrett's esophagus	0.000952	0.00356	CcSEcCtD
Irbesartan—Jaundice—Omeprazole—Barrett's esophagus	0.000944	0.00353	CcSEcCtD
Irbesartan—Jaundice—Esomeprazole—Barrett's esophagus	0.000944	0.00353	CcSEcCtD
Irbesartan—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000941	0.00352	CcSEcCtD
Irbesartan—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000941	0.00352	CcSEcCtD
Irbesartan—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000941	0.00352	CcSEcCtD
Irbesartan—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000941	0.00352	CcSEcCtD
Irbesartan—PTGS1—digestive system—Barrett's esophagus	0.00092	0.0259	CbGeAlD
Irbesartan—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000916	0.00342	CcSEcCtD
Irbesartan—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000916	0.00342	CcSEcCtD
Irbesartan—Epistaxis—Esomeprazole—Barrett's esophagus	0.000913	0.00341	CcSEcCtD
Irbesartan—Epistaxis—Omeprazole—Barrett's esophagus	0.000913	0.00341	CcSEcCtD
Irbesartan—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000903	0.00338	CcSEcCtD
Irbesartan—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000903	0.00338	CcSEcCtD
Irbesartan—Bradycardia—Omeprazole—Barrett's esophagus	0.000885	0.00331	CcSEcCtD
Irbesartan—Bradycardia—Esomeprazole—Barrett's esophagus	0.000885	0.00331	CcSEcCtD
Irbesartan—Rhinitis—Omeprazole—Barrett's esophagus	0.000871	0.00326	CcSEcCtD
Irbesartan—Rhinitis—Esomeprazole—Barrett's esophagus	0.000871	0.00326	CcSEcCtD
Irbesartan—Hepatitis—Esomeprazole—Barrett's esophagus	0.000869	0.00325	CcSEcCtD
Irbesartan—Hepatitis—Omeprazole—Barrett's esophagus	0.000869	0.00325	CcSEcCtD
Irbesartan—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000865	0.00323	CcSEcCtD
Irbesartan—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000865	0.00323	CcSEcCtD
Irbesartan—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000862	0.00323	CcSEcCtD
Irbesartan—Pharyngitis—Omeprazole—Barrett's esophagus	0.000862	0.00323	CcSEcCtD
Irbesartan—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000858	0.00321	CcSEcCtD
Irbesartan—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000858	0.00321	CcSEcCtD
Irbesartan—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000856	0.0032	CcSEcCtD
Irbesartan—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000856	0.0032	CcSEcCtD
Irbesartan—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000854	0.00319	CcSEcCtD
Irbesartan—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000854	0.00319	CcSEcCtD
Irbesartan—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000852	0.00319	CcSEcCtD
Irbesartan—Urethral disorder—Omeprazole—Barrett's esophagus	0.000852	0.00319	CcSEcCtD
Irbesartan—Visual impairment—Esomeprazole—Barrett's esophagus	0.000837	0.00313	CcSEcCtD
Irbesartan—Visual impairment—Omeprazole—Barrett's esophagus	0.000837	0.00313	CcSEcCtD
Irbesartan—Tinnitus—Omeprazole—Barrett's esophagus	0.00081	0.00303	CcSEcCtD
Irbesartan—Tinnitus—Esomeprazole—Barrett's esophagus	0.00081	0.00303	CcSEcCtD
Irbesartan—Flushing—Esomeprazole—Barrett's esophagus	0.000806	0.00302	CcSEcCtD
Irbesartan—Flushing—Omeprazole—Barrett's esophagus	0.000806	0.00302	CcSEcCtD
Irbesartan—JUN—FGF signaling pathway—HGF—Barrett's esophagus	0.000787	0.00715	CbGpPWpGaD
Irbesartan—Immune system disorder—Omeprazole—Barrett's esophagus	0.000785	0.00294	CcSEcCtD
Irbesartan—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000785	0.00294	CcSEcCtD
Irbesartan—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000783	0.00293	CcSEcCtD
Irbesartan—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000783	0.00293	CcSEcCtD
Irbesartan—Chills—Esomeprazole—Barrett's esophagus	0.00078	0.00292	CcSEcCtD
Irbesartan—Chills—Omeprazole—Barrett's esophagus	0.00078	0.00292	CcSEcCtD
Irbesartan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000778	0.00707	CbGpPWpGaD
Irbesartan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000778	0.00707	CbGpPWpGaD
Irbesartan—CYP3A4—digestive system—Barrett's esophagus	0.000768	0.0216	CbGeAlD
Irbesartan—Malnutrition—Esomeprazole—Barrett's esophagus	0.000756	0.00283	CcSEcCtD
Irbesartan—Malnutrition—Omeprazole—Barrett's esophagus	0.000756	0.00283	CcSEcCtD
Irbesartan—CYP2D6—digestive system—Barrett's esophagus	0.000756	0.0213	CbGeAlD
Irbesartan—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000754	0.00686	CbGpPWpGaD
Irbesartan—Flatulence—Omeprazole—Barrett's esophagus	0.000745	0.00279	CcSEcCtD
Irbesartan—Flatulence—Esomeprazole—Barrett's esophagus	0.000745	0.00279	CcSEcCtD
Irbesartan—Tension—Esomeprazole—Barrett's esophagus	0.000742	0.00278	CcSEcCtD
Irbesartan—Tension—Omeprazole—Barrett's esophagus	0.000742	0.00278	CcSEcCtD
Irbesartan—Dysgeusia—Omeprazole—Barrett's esophagus	0.000741	0.00277	CcSEcCtD
Irbesartan—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000741	0.00277	CcSEcCtD
Irbesartan—Nervousness—Esomeprazole—Barrett's esophagus	0.000735	0.00275	CcSEcCtD
Irbesartan—Nervousness—Omeprazole—Barrett's esophagus	0.000735	0.00275	CcSEcCtD
Irbesartan—JUN—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.00073	0.00663	CbGpPWpGaD
Irbesartan—Muscle spasms—Omeprazole—Barrett's esophagus	0.000727	0.00272	CcSEcCtD
Irbesartan—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000727	0.00272	CcSEcCtD
Irbesartan—JUN—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000726	0.0066	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.000714	0.00649	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000714	0.00649	CbGpPWpGaD
Irbesartan—Vision blurred—Omeprazole—Barrett's esophagus	0.000713	0.00267	CcSEcCtD
Irbesartan—Vision blurred—Esomeprazole—Barrett's esophagus	0.000713	0.00267	CcSEcCtD
Irbesartan—JUN—Osteopontin-mediated events—RELA—Barrett's esophagus	0.000712	0.00647	CbGpPWpGaD
Irbesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00071	0.00646	CbGpPWpGaD
Irbesartan—Tremor—Esomeprazole—Barrett's esophagus	0.000709	0.00265	CcSEcCtD
Irbesartan—Tremor—Omeprazole—Barrett's esophagus	0.000709	0.00265	CcSEcCtD
Irbesartan—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000702	0.00262	CcSEcCtD
Irbesartan—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000702	0.00262	CcSEcCtD
Irbesartan—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000701	0.00637	CbGpPWpGaD
Irbesartan—Anaemia—Omeprazole—Barrett's esophagus	0.000699	0.00261	CcSEcCtD
Irbesartan—Anaemia—Esomeprazole—Barrett's esophagus	0.000699	0.00261	CcSEcCtD
Irbesartan—Agitation—Omeprazole—Barrett's esophagus	0.000695	0.0026	CcSEcCtD
Irbesartan—Agitation—Esomeprazole—Barrett's esophagus	0.000695	0.0026	CcSEcCtD
Irbesartan—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000693	0.0063	CbGpPWpGaD
Irbesartan—Angioedema—Omeprazole—Barrett's esophagus	0.000691	0.00258	CcSEcCtD
Irbesartan—Angioedema—Esomeprazole—Barrett's esophagus	0.000691	0.00258	CcSEcCtD
Irbesartan—EDNRA—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000689	0.00626	CbGpPWpGaD
Irbesartan—Malaise—Esomeprazole—Barrett's esophagus	0.000682	0.00255	CcSEcCtD
Irbesartan—Malaise—Omeprazole—Barrett's esophagus	0.000682	0.00255	CcSEcCtD
Irbesartan—Vertigo—Esomeprazole—Barrett's esophagus	0.00068	0.00254	CcSEcCtD
Irbesartan—Vertigo—Omeprazole—Barrett's esophagus	0.00068	0.00254	CcSEcCtD
Irbesartan—Leukopenia—Esomeprazole—Barrett's esophagus	0.000677	0.00253	CcSEcCtD
Irbesartan—Leukopenia—Omeprazole—Barrett's esophagus	0.000677	0.00253	CcSEcCtD
Irbesartan—JUN—Presenilin action in Notch and Wnt signaling—APC—Barrett's esophagus	0.000664	0.00604	CbGpPWpGaD
Irbesartan—JUN—IL1-mediated signaling events—RELA—Barrett's esophagus	0.000661	0.00601	CbGpPWpGaD
Irbesartan—Cough—Omeprazole—Barrett's esophagus	0.00066	0.00247	CcSEcCtD
Irbesartan—Cough—Esomeprazole—Barrett's esophagus	0.00066	0.00247	CcSEcCtD
Irbesartan—Hypertension—Esomeprazole—Barrett's esophagus	0.000653	0.00244	CcSEcCtD
Irbesartan—Hypertension—Omeprazole—Barrett's esophagus	0.000653	0.00244	CcSEcCtD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.00065	0.00591	CbGpPWpGaD
Irbesartan—Myalgia—Esomeprazole—Barrett's esophagus	0.000644	0.00241	CcSEcCtD
Irbesartan—Myalgia—Omeprazole—Barrett's esophagus	0.000644	0.00241	CcSEcCtD
Irbesartan—Chest pain—Omeprazole—Barrett's esophagus	0.000644	0.00241	CcSEcCtD
Irbesartan—Arthralgia—Omeprazole—Barrett's esophagus	0.000644	0.00241	CcSEcCtD
Irbesartan—Chest pain—Esomeprazole—Barrett's esophagus	0.000644	0.00241	CcSEcCtD
Irbesartan—Arthralgia—Esomeprazole—Barrett's esophagus	0.000644	0.00241	CcSEcCtD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—Barrett's esophagus	0.000642	0.00584	CbGpPWpGaD
Irbesartan—Anxiety—Omeprazole—Barrett's esophagus	0.000642	0.0024	CcSEcCtD
Irbesartan—Anxiety—Esomeprazole—Barrett's esophagus	0.000642	0.0024	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00064	0.00239	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00064	0.00239	CcSEcCtD
Irbesartan—Discomfort—Esomeprazole—Barrett's esophagus	0.000636	0.00238	CcSEcCtD
Irbesartan—Discomfort—Omeprazole—Barrett's esophagus	0.000636	0.00238	CcSEcCtD
Irbesartan—JUN—CD40/CD40L signaling—RELA—Barrett's esophagus	0.000632	0.00574	CbGpPWpGaD
Irbesartan—Dry mouth—Omeprazole—Barrett's esophagus	0.00063	0.00236	CcSEcCtD
Irbesartan—Dry mouth—Esomeprazole—Barrett's esophagus	0.00063	0.00236	CcSEcCtD
Irbesartan—JUN—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.000628	0.0057	CbGpPWpGaD
Irbesartan—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000617	0.00231	CcSEcCtD
Irbesartan—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000617	0.00231	CcSEcCtD
Irbesartan—Infection—Omeprazole—Barrett's esophagus	0.000613	0.00229	CcSEcCtD
Irbesartan—Infection—Esomeprazole—Barrett's esophagus	0.000613	0.00229	CcSEcCtD
Irbesartan—Shock—Esomeprazole—Barrett's esophagus	0.000607	0.00227	CcSEcCtD
Irbesartan—Shock—Omeprazole—Barrett's esophagus	0.000607	0.00227	CcSEcCtD
Irbesartan—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000605	0.00226	CcSEcCtD
Irbesartan—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000605	0.00226	CcSEcCtD
Irbesartan—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000604	0.00226	CcSEcCtD
Irbesartan—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000604	0.00226	CcSEcCtD
Irbesartan—Tachycardia—Esomeprazole—Barrett's esophagus	0.000603	0.00225	CcSEcCtD
Irbesartan—Tachycardia—Omeprazole—Barrett's esophagus	0.000603	0.00225	CcSEcCtD
Irbesartan—JUN—Copper homeostasis—APC—Barrett's esophagus	0.000602	0.00547	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000601	0.00546	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000601	0.00546	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.0006	0.00545	CbGpPWpGaD
Irbesartan—Skin disorder—Omeprazole—Barrett's esophagus	0.0006	0.00224	CcSEcCtD
Irbesartan—Skin disorder—Esomeprazole—Barrett's esophagus	0.0006	0.00224	CcSEcCtD
Irbesartan—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000597	0.00223	CcSEcCtD
Irbesartan—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000597	0.00223	CcSEcCtD
Irbesartan—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000593	0.00539	CbGpPWpGaD
Irbesartan—Anorexia—Esomeprazole—Barrett's esophagus	0.000588	0.0022	CcSEcCtD
Irbesartan—Anorexia—Omeprazole—Barrett's esophagus	0.000588	0.0022	CcSEcCtD
Irbesartan—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000583	0.0053	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Barrett's esophagus	0.000582	0.00529	CbGpPWpGaD
Irbesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000578	0.00525	CbGpPWpGaD
Irbesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000576	0.00523	CbGpPWpGaD
Irbesartan—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000576	0.00523	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000575	0.00522	CbGpPWpGaD
Irbesartan—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000571	0.00519	CbGpPWpGaD
Irbesartan—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000562	0.0021	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000562	0.0021	CcSEcCtD
Irbesartan—JUN—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000558	0.00507	CbGpPWpGaD
Irbesartan—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000554	0.00207	CcSEcCtD
Irbesartan—Paraesthesia—Omeprazole—Barrett's esophagus	0.000554	0.00207	CcSEcCtD
Irbesartan—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00055	0.00206	CcSEcCtD
Irbesartan—Dyspnoea—Omeprazole—Barrett's esophagus	0.00055	0.00206	CcSEcCtD
Irbesartan—Somnolence—Esomeprazole—Barrett's esophagus	0.000549	0.00205	CcSEcCtD
Irbesartan—Somnolence—Omeprazole—Barrett's esophagus	0.000549	0.00205	CcSEcCtD
Irbesartan—Dyspepsia—Omeprazole—Barrett's esophagus	0.000543	0.00203	CcSEcCtD
Irbesartan—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000543	0.00203	CcSEcCtD
Irbesartan—AGTR1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00054	0.00491	CbGpPWpGaD
Irbesartan—Decreased appetite—Omeprazole—Barrett's esophagus	0.000537	0.00201	CcSEcCtD
Irbesartan—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000537	0.00201	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000533	0.00199	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000533	0.00199	CcSEcCtD
Irbesartan—Fatigue—Esomeprazole—Barrett's esophagus	0.000532	0.00199	CcSEcCtD
Irbesartan—Fatigue—Omeprazole—Barrett's esophagus	0.000532	0.00199	CcSEcCtD
Irbesartan—Pain—Omeprazole—Barrett's esophagus	0.000528	0.00197	CcSEcCtD
Irbesartan—Pain—Esomeprazole—Barrett's esophagus	0.000528	0.00197	CcSEcCtD
Irbesartan—Constipation—Omeprazole—Barrett's esophagus	0.000528	0.00197	CcSEcCtD
Irbesartan—Constipation—Esomeprazole—Barrett's esophagus	0.000528	0.00197	CcSEcCtD
Irbesartan—JUN—Selenium Metabolism and Selenoproteins—RELA—Barrett's esophagus	0.00051	0.00464	CbGpPWpGaD
Irbesartan—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000509	0.0019	CcSEcCtD
Irbesartan—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000509	0.0019	CcSEcCtD
Irbesartan—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000505	0.00189	CcSEcCtD
Irbesartan—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000505	0.00189	CcSEcCtD
Irbesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000496	0.0045	CbGpPWpGaD
Irbesartan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000494	0.00449	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway—APC—Barrett's esophagus	0.000492	0.00447	CbGpPWpGaD
Irbesartan—Urticaria—Omeprazole—Barrett's esophagus	0.00049	0.00183	CcSEcCtD
Irbesartan—Urticaria—Esomeprazole—Barrett's esophagus	0.00049	0.00183	CcSEcCtD
Irbesartan—Body temperature increased—Omeprazole—Barrett's esophagus	0.000488	0.00183	CcSEcCtD
Irbesartan—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000488	0.00183	CcSEcCtD
Irbesartan—Abdominal pain—Omeprazole—Barrett's esophagus	0.000488	0.00183	CcSEcCtD
Irbesartan—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000488	0.00183	CcSEcCtD
Irbesartan—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000488	0.00443	CbGpPWpGaD
Irbesartan—JUN—Regulation of retinoblastoma protein—PPARG—Barrett's esophagus	0.00048	0.00437	CbGpPWpGaD
Irbesartan—JUN—CDC42 signaling events—APC—Barrett's esophagus	0.000475	0.00432	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000474	0.0043	CbGpPWpGaD
Irbesartan—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000473	0.0043	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000473	0.0043	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.000472	0.00429	CbGpPWpGaD
Irbesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000469	0.00426	CbGpPWpGaD
Irbesartan—JUN—IL-3 Signaling Pathway—CXCL8—Barrett's esophagus	0.000465	0.00423	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000462	0.0042	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000458	0.00416	CbGpPWpGaD
Irbesartan—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000455	0.0017	CcSEcCtD
Irbesartan—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000455	0.0017	CcSEcCtD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.00045	0.00409	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—RELA—Barrett's esophagus	0.00045	0.00409	CbGpPWpGaD
Irbesartan—Asthenia—Omeprazole—Barrett's esophagus	0.000443	0.00166	CcSEcCtD
Irbesartan—Asthenia—Esomeprazole—Barrett's esophagus	0.000443	0.00166	CcSEcCtD
Irbesartan—UGT1A3—NRF2 pathway—HGF—Barrett's esophagus	0.00044	0.004	CbGpPWpGaD
Irbesartan—Pruritus—Esomeprazole—Barrett's esophagus	0.000437	0.00163	CcSEcCtD
Irbesartan—Pruritus—Omeprazole—Barrett's esophagus	0.000437	0.00163	CcSEcCtD
Irbesartan—JUN—Pre-NOTCH Transcription and Translation—TP53—Barrett's esophagus	0.000434	0.00395	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000427	0.00388	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.000427	0.00388	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000425	0.00386	CbGpPWpGaD
Irbesartan—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000422	0.00158	CcSEcCtD
Irbesartan—Diarrhoea—Omeprazole—Barrett's esophagus	0.000422	0.00158	CcSEcCtD
Irbesartan—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000417	0.00378	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000414	0.00376	CbGpPWpGaD
Irbesartan—Dizziness—Omeprazole—Barrett's esophagus	0.000408	0.00153	CcSEcCtD
Irbesartan—Dizziness—Esomeprazole—Barrett's esophagus	0.000408	0.00153	CcSEcCtD
Irbesartan—JUN—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.000404	0.00367	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000401	0.00364	CbGpPWpGaD
Irbesartan—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000401	0.00364	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—RELA—Barrett's esophagus	0.000399	0.00362	CbGpPWpGaD
Irbesartan—Vomiting—Esomeprazole—Barrett's esophagus	0.000393	0.00147	CcSEcCtD
Irbesartan—Vomiting—Omeprazole—Barrett's esophagus	0.000393	0.00147	CcSEcCtD
Irbesartan—Rash—Esomeprazole—Barrett's esophagus	0.000389	0.00146	CcSEcCtD
Irbesartan—Rash—Omeprazole—Barrett's esophagus	0.000389	0.00146	CcSEcCtD
Irbesartan—JUN—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000389	0.00353	CbGpPWpGaD
Irbesartan—Dermatitis—Esomeprazole—Barrett's esophagus	0.000389	0.00145	CcSEcCtD
Irbesartan—Dermatitis—Omeprazole—Barrett's esophagus	0.000389	0.00145	CcSEcCtD
Irbesartan—Headache—Esomeprazole—Barrett's esophagus	0.000387	0.00145	CcSEcCtD
Irbesartan—Headache—Omeprazole—Barrett's esophagus	0.000387	0.00145	CcSEcCtD
Irbesartan—JUN—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000386	0.0035	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—RELA—Barrett's esophagus	0.000384	0.00349	CbGpPWpGaD
Irbesartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000381	0.00347	CbGpPWpGaD
Irbesartan—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000376	0.00342	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.000376	0.00341	CbGpPWpGaD
Irbesartan—JUN—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000374	0.0034	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—HGF—Barrett's esophagus	0.000367	0.00334	CbGpPWpGaD
Irbesartan—Nausea—Omeprazole—Barrett's esophagus	0.000367	0.00137	CcSEcCtD
Irbesartan—Nausea—Esomeprazole—Barrett's esophagus	0.000367	0.00137	CcSEcCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000363	0.00329	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—SST—Barrett's esophagus	0.000352	0.0032	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—APC—Barrett's esophagus	0.000351	0.00319	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000351	0.00319	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.00035	0.00318	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000347	0.00315	CbGpPWpGaD
Irbesartan—JUN—ATM Signaling Pathway—TP53—Barrett's esophagus	0.000336	0.00305	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—CDKN2A—Barrett's esophagus	0.000333	0.00303	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.000333	0.00303	CbGpPWpGaD
Irbesartan—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000329	0.00299	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000327	0.00297	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—RELA—Barrett's esophagus	0.000321	0.00291	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000318	0.00289	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000315	0.00286	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000314	0.00286	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.000313	0.00284	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000309	0.00281	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000309	0.00281	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000308	0.0028	CbGpPWpGaD
Irbesartan—JUN—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000306	0.00278	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000306	0.00278	CbGpPWpGaD
Irbesartan—JUN—Pre-NOTCH Expression and Processing—TP53—Barrett's esophagus	0.000306	0.00278	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000303	0.00276	CbGpPWpGaD
Irbesartan—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000302	0.00274	CbGpPWpGaD
Irbesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.0003	0.00272	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000298	0.00271	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000293	0.00266	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—GAST—Barrett's esophagus	0.00029	0.00264	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—HGF—Barrett's esophagus	0.000288	0.00261	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000286	0.0026	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—RELA—Barrett's esophagus	0.000281	0.00256	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—Barrett's esophagus	0.000279	0.00253	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000279	0.00253	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—SST—Barrett's esophagus	0.000276	0.00251	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000275	0.00249	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—APC—Barrett's esophagus	0.000273	0.00248	CbGpPWpGaD
Irbesartan—JUN—Copper homeostasis—TP53—Barrett's esophagus	0.000272	0.00247	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.000271	0.00246	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000268	0.00244	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—RELA—Barrett's esophagus	0.000268	0.00244	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—APC—Barrett's esophagus	0.000267	0.00242	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000264	0.0024	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—GAST—Barrett's esophagus	0.000263	0.00239	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000259	0.00235	CbGpPWpGaD
Irbesartan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000256	0.00233	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000253	0.0023	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000253	0.0023	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—Barrett's esophagus	0.000253	0.0023	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—CDKN2A—Barrett's esophagus	0.000252	0.00229	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000251	0.00228	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000249	0.00226	CbGpPWpGaD
Irbesartan—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000248	0.00225	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000246	0.00223	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00024	0.00218	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000238	0.00216	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000228	0.00207	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000216	0.00196	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000215	0.00195	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000214	0.00195	CbGpPWpGaD
Irbesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000213	0.00193	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000213	0.00193	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000213	0.00193	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000212	0.00193	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000211	0.00191	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00021	0.00191	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.00021	0.0019	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—RELA—Barrett's esophagus	0.000208	0.00189	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—GAST—Barrett's esophagus	0.000207	0.00188	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000202	0.00184	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—SST—Barrett's esophagus	0.000199	0.00181	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000198	0.0018	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000197	0.00179	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGES—Barrett's esophagus	0.00019	0.00172	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000189	0.00172	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TP53—Barrett's esophagus	0.000185	0.00169	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000184	0.00167	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—SST—Barrett's esophagus	0.000181	0.00164	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00018	0.00164	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000177	0.00161	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN2A—Barrett's esophagus	0.000176	0.0016	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	0.000174	0.00158	CbGpPWpGaD
Irbesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000173	0.00157	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—RELA—Barrett's esophagus	0.00017	0.00154	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000164	0.00149	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000163	0.00148	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000162	0.00147	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000162	0.00147	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CXCL8—Barrett's esophagus	0.00016	0.00145	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—TP53—Barrett's esophagus	0.000159	0.00144	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000158	0.00144	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—SST—Barrett's esophagus	0.000156	0.00142	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GAST—Barrett's esophagus	0.000156	0.00141	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000155	0.00141	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000155	0.00141	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—Barrett's esophagus	0.000151	0.00137	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000151	0.00137	CbGpPWpGaD
Irbesartan—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000148	0.00134	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP26A1—Barrett's esophagus	0.000144	0.00131	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—SST—Barrett's esophagus	0.000142	0.00129	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000141	0.00128	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—Barrett's esophagus	0.00014	0.00128	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000137	0.00125	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN2A—Barrett's esophagus	0.000133	0.00121	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	0.000129	0.00117	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—RELA—Barrett's esophagus	0.000128	0.00117	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000126	0.00115	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—Barrett's esophagus	0.000123	0.00112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GAST—Barrett's esophagus	0.000122	0.00111	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CXCL8—Barrett's esophagus	0.000121	0.0011	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000116	0.00105	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000108	0.00098	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000108	0.000977	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGES—Barrett's esophagus	0.000107	0.000971	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SST—Barrett's esophagus	0.000107	0.000969	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000107	0.000968	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC9A1—Barrett's esophagus	0.000104	0.000942	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—Barrett's esophagus	9.82e-05	0.000892	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	9.61e-05	0.000874	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—Barrett's esophagus	9.23e-05	0.000839	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GAST—Barrett's esophagus	9.12e-05	0.000829	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SST—Barrett's esophagus	8.37e-05	0.00076	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	8.1e-05	0.000736	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL8—Barrett's esophagus	7.75e-05	0.000704	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—Barrett's esophagus	7.42e-05	0.000674	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL8—Barrett's esophagus	7.03e-05	0.000639	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGES—Barrett's esophagus	6.9e-05	0.000627	CbGpPWpGaD
Irbesartan—JUN—Immune System—HGF—Barrett's esophagus	6.89e-05	0.000626	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—RELA—Barrett's esophagus	6.86e-05	0.000624	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SST—Barrett's esophagus	6.25e-05	0.000568	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL8—Barrett's esophagus	6.08e-05	0.000552	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.99e-05	0.000544	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	5.84e-05	0.000531	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGES—Barrett's esophagus	5.67e-05	0.000515	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APC—Barrett's esophagus	5.64e-05	0.000513	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGES—Barrett's esophagus	5.62e-05	0.000511	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—Barrett's esophagus	5.52e-05	0.000502	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	5.23e-05	0.000475	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGES—Barrett's esophagus	4.8e-05	0.000436	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PPARG—Barrett's esophagus	4.73e-05	0.00043	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.71e-05	0.000428	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APC—Barrett's esophagus	4.43e-05	0.000402	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RELA—Barrett's esophagus	4.41e-05	0.000401	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	4.3e-05	0.00039	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	4.26e-05	0.000387	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—Barrett's esophagus	4.16e-05	0.000378	CbGpPWpGaD
Irbesartan—JUN—Immune System—RELA—Barrett's esophagus	4e-05	0.000363	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.87e-05	0.000351	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	3.77e-05	0.000343	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—Barrett's esophagus	3.72e-05	0.000338	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.71e-05	0.000337	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	3.64e-05	0.000331	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RELA—Barrett's esophagus	3.46e-05	0.000314	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APC—Barrett's esophagus	3.31e-05	0.000301	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—Barrett's esophagus	3.26e-05	0.000296	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.15e-05	0.000286	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	3.1e-05	0.000281	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	3.07e-05	0.000279	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.04e-05	0.000276	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.81e-05	0.000255	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.69e-05	0.000244	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARG—Barrett's esophagus	2.67e-05	0.000242	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	2.62e-05	0.000238	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RELA—Barrett's esophagus	2.58e-05	0.000235	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—Barrett's esophagus	2.55e-05	0.000232	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.48e-05	0.000225	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—Barrett's esophagus	2.44e-05	0.000221	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.12e-05	0.000192	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—Barrett's esophagus	2.1e-05	0.000191	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.02e-05	0.000184	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—Barrett's esophagus	2e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.72e-05	0.000156	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—Barrett's esophagus	1.49e-05	0.000136	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.41e-05	0.000128	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARG—Barrett's esophagus	1.4e-05	0.000127	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	1.35e-05	0.000123	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARG—Barrett's esophagus	1.2e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	1.11e-05	0.000101	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	1.1e-05	0.0001	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	9.42e-06	8.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARG—Barrett's esophagus	9.24e-06	8.4e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	7.27e-06	6.61e-05	CbGpPWpGaD
